First Time Loading...

Max Healthcare Institute Ltd
NSE:MAXHEALTH

Watchlist Manager
Max Healthcare Institute Ltd Logo
Max Healthcare Institute Ltd
NSE:MAXHEALTH
Watchlist
Price: 805.05 INR -0.83%
Updated: Jun 11, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

54.1B
+4%
Revenue
Growth Rates:
1 Year
+18%
3 Years
+116%
5 Years
-
7 Years
-
10 Years
-
12.5B
+2%
Operating Income
Growth Rates:
1 Year
+23%
3 Years
+442%
5 Years
-
7 Years
-
10 Years
-
10.6B
+0.1%
Net Income
Growth Rates:
1 Year
-4%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Earnings Waterfall
Max Healthcare Institute Ltd

Revenue
54.1B INR
Cost of Revenue
-11.2B INR
Gross Profit
42.9B INR
Operating Expenses
-30.4B INR
Operating Income
12.5B INR
Other Expenses
-1.9B INR
Net Income
10.6B INR

Income Statement
Max Healthcare Institute Ltd

Rotate your device to view
Income Statement
Currency: INR
Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
10 590
N/A
10 518
-1%
14 222
+35%
19 507
+37%
25 047
+28%
32 486
+30%
36 160
+11%
37 945
+5%
39 315
+4%
39 976
+2%
41 164
+3%
42 834
+4%
45 626
+7%
47 813
+5%
50 074
+5%
52 011
+4%
54 060
+4%
Gross Profit
Cost of Revenue
(2 173)
(2 284)
(3 354)
(4 730)
(6 458)
(7 896)
(8 811)
(8 991)
(9 856)
(8 823)
(8 554)
(8 758)
(9 909)
(9 781)
(10 315)
(10 690)
(11 185)
Gross Profit
8 417
N/A
8 234
-2%
10 868
+32%
14 777
+36%
18 589
+26%
24 590
+32%
27 349
+11%
28 955
+6%
29 459
+2%
31 153
+6%
32 610
+5%
34 077
+4%
35 717
+5%
38 032
+6%
39 758
+5%
41 321
+4%
42 875
+4%
Operating Income
Operating Expenses
(7 938)
(8 385)
(10 835)
(13 736)
(16 289)
(20 006)
(21 264)
(22 081)
(22 061)
(23 804)
(24 501)
(25 310)
(25 601)
(27 206)
(28 249)
(29 127)
(30 404)
Selling, General & Administrative
(4 771)
(5 009)
(6 600)
(8 799)
(14 479)
(13 576)
(14 764)
(15 333)
(19 812)
(16 261)
(16 630)
(17 120)
(23 222)
(18 571)
(19 292)
(19 888)
(20 513)
Depreciation & Amortization
(456)
(595)
(1 007)
(1 383)
(1 741)
(2 015)
(2 034)
(2 103)
(2 211)
(2 247)
(2 285)
(2 303)
(2 322)
(2 309)
(2 311)
(2 350)
(2 450)
Other Operating Expenses
(2 711)
(2 782)
(3 228)
(3 554)
(69)
(4 415)
(4 466)
(4 646)
(38)
(5 297)
(5 586)
(5 887)
(57)
(6 326)
(6 646)
(6 889)
(7 441)
Operating Income
479
N/A
(151)
N/A
33
N/A
1 041
+3 044%
2 300
+121%
4 584
+99%
6 085
+33%
6 873
+13%
7 398
+8%
7 348
-1%
8 109
+10%
8 767
+8%
10 116
+15%
10 827
+7%
11 509
+6%
12 194
+6%
12 471
+2%
Pre-Tax Income
Interest Income Expense
(832)
(1 084)
(1 408)
(1 427)
(1 093)
(1 538)
(1 076)
(838)
(329)
(937)
(1 085)
(1 233)
120
(809)
(676)
(587)
(599)
Non-Reccuring Items
0
(2 337)
(2 337)
(2 337)
(2 337)
0
(79)
(90)
(90)
(90)
(11)
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
(2)
0
0
0
(31)
0
0
0
13
0
0
0
0
Total Other Income
481
609
973
1 090
446
1 168
879
945
441
1 334
1 478
1 641
388
1 491
1 687
1 696
1 781
Pre-Tax Income
128
N/A
(2 963)
N/A
(2 739)
+8%
(1 633)
+40%
(687)
+58%
4 214
N/A
5 808
+38%
6 890
+19%
7 389
+7%
7 654
+4%
8 490
+11%
9 174
+8%
10 637
+16%
11 508
+8%
12 520
+9%
13 303
+6%
13 653
+3%
Net Income
Tax Provision
1
90
35
(111)
(459)
(978)
(1 292)
(1 380)
(1 339)
(1 345)
946
589
398
199
(2 619)
(2 733)
(3 077)
Income from Continuing Operations
129
(2 873)
(2 704)
(1 744)
(1 145)
3 236
4 516
5 510
6 051
6 310
9 437
9 763
11 035
11 708
9 901
10 570
10 576
Equity Earnings Affiliates
461
230
241
203
(231)
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
590
N/A
(2 643)
N/A
(2 463)
+7%
(1 541)
+37%
(1 376)
+11%
3 236
N/A
4 516
+40%
5 510
+22%
6 051
+10%
6 310
+4%
9 437
+50%
9 763
+3%
11 035
+13%
11 708
+6%
9 901
-15%
10 570
+7%
10 576
+0%
EPS (Diluted)
0.65
N/A
-2.92
N/A
-2.73
+7%
-1.71
+37%
-1.59
+7%
3.32
N/A
4.65
+40%
5.69
+22%
6.24
+10%
6.5
+4%
9.72
+50%
10.05
+3%
11.36
+13%
11.99
+6%
10.16
-15%
10.84
+7%
10.84
N/A

See Also

Summary
MAXHEALTH intrinsic value, competitors valuation, and company profile.
DCF Valuation
MAXHEALTH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MAXHEALTH stock valuation using valuation multiples.
Wall Street Estimates
MAXHEALTH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MAXHEALTH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 146,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.